Splenomegaly in Children and Adolescents

by Meinolf Suttorp, Meinolf Suttorp, Carl Friedrich Classen
Published 2021-07-01

Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.

by Doreen William, Madlin Walther, Björn Schneider, Michael Linnebacher, Carl Friedrich Classen
Published 2018-01-01

Establishment and characterization of primary glioblastoma cell lines from fresh and frozen material: a detailed comparison.

by Christina Susanne Mullins, Björn Schneider, Florian Stockhammer, Mathias Krohn, Carl Friedrich Classen, Michael Linnebacher
Published 2013-01-01

Amplification of the EGFR gene can be maintained and modulated by variation of EGF concentrations in in vitro models of glioblastoma multiforme.

by Doreen William, Poroshista Mokri, Nora Lamp, Michael Linnebacher, Carl Friedrich Classen, Andreas Erbersdobler, Björn Schneider
Published 2017-01-01

Arginine-Depleting Enzymes – An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies

by Christin Riess, Fatemeh Shokraie, Carl Friedrich Classen, Bernd Kreikemeyer, Tomas Fiedler, Christian Junghanss, Claudia Maletzki
Published 2018-11-01

Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models

by Christin Riess, Dirk Koczan, Björn Schneider, Charlotte Linke, Katharina del Moral, Carl Friedrich Classen, Claudia Maletzki
Published 2021-03-01

The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C

by Charlotte Linke, Thomas Freitag, Christin Riess, Jana Vanessa Scheffler, Katharina del Moral, Nina Schoenwaelder, Tomas Fiedler, Adina Fiebig, Philipp Kaps, Daniel Dubinski, Björn Schneider, Wendy Bergmann, Carl Friedrich Classen, Claudia Maletzki
Published 2023-02-01

Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib

by Christin Riess, Christin Riess, Christin Riess, Björn Schneider, Hanna Kehnscherper, Julia Gesche, Nina Irmscher, Fatemeh Shokraie, Carl Friedrich Classen, Elisa Wirthgen, Grazyna Domanska, Annette Zimpfer, Daniel Strüder, Christian Junghanss, Claudia Maletzki
Published 2020-02-01

Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells

by Christin Riess, Katharina del Moral, Adina Fiebig, Philipp Kaps, Charlotte Linke, Burkhard Hinz, Anne Rupprecht, Marcus Frank, Tomas Fiedler, Dirk Koczan, Sascha Troschke-Meurer, Holger N. Lode, Nadja Engel, Thomas Freitag, Carl Friedrich Classen, Claudia Maletzki
Published 2022-06-01

Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells

by Sarah Rehbein, Anna-Lena Possmayer, Süleyman Bozkurt, Catharina Lotsch, Julia Gerstmeier, Michael Burger, Stefan Momma, Claudia Maletzki, Carl Friedrich Classen, Thomas M. Freiman, Daniel Dubinski, Katrin Lamszus, Brett W. Stringer, Christel Herold-Mende, Christian Münch, Donat Kögel, Benedikt Linder
Published 2023-10-01

Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up

by Georg Seifert, Sarah B. Blakeslee, Gabriele Calaminus, Farid I. Kandil, Andrea Barth, Toralf Bernig, Carl Friedrich Classen, Selim Corbacioglu, Jürgen Föll, Sven Gottschling, Bernd Gruhn, Claudia vom Hoff-Heise, Holger N. Lode, David Martin, Michaela Nathrath, Felix Neunhoeffer, Arnulf Pekrun, Beate Wulff, Tycho Zuzak, Günter Henze, Alfred Längler
Published 2022-06-01